# Elucidation of the pramanicin biosynthetic pathway reveals a DUF2306 family membrane protein involved in terminal epoxidation

**Authors:** Yang-Le Gao, Wei Chen, Jing-Jing Zhang, Pei-Lin Li, Li Li, Hui Zhang

PMC · DOI: 10.3389/fmicb.2026.1765828 · 2026-01-29

## TL;DR

Researchers discovered how the fungus Macrophomina phaseolina makes pramanicin, a compound with antifungal and anticancer properties, and identified a new enzyme family involved in its production.

## Contribution

The first functional assignment of a DUF2306 family protein in natural product biosynthesis is established.

## Key findings

- PraA synthesizes a linear precursor that cyclizes to form pre-pramanicin.
- PraC, a DUF2306 family protein, is essential for the final epoxidation step in pramanicin biosynthesis.
- Combinatorial expression and feeding experiments confirmed the role of PraC in forming the bioactive epoxide.

## Abstract

Pramanicin is a fungal metabolite with notable biological activities, including antifungal and anticancer properties. While its chemical synthesis has been achieved, its biosynthetic pathway has remained elusive. Here, we report the identification of the pramanicin biosynthetic gene cluster from the fungus Macrophomina phaseolina. Heterologous expression in Aspergillus nidulans demonstrated that the hybrid polyketide-nonribosomal (PKS-NRPS) enzyme PraA synthesizes a linear precursor that cyclizes to form pre-pramanicin. The flavin-dependent monooxygenase PraD and short-chain dehydrogenase/reductase PraB subsequently catalyze a hydroxylation and ketoreduction to yield pramanicin-A. Notably, we established that the final epoxidation step requires the PraC—a membrane-integrated protein of the previously uncharacterized DUF2306 family. This represents the first functional assignment of a DUF2306 family protein in natural product biosynthesis. Combinatorial expression and in vivo feeding experiments confirmed that PraC is essential for the formation of the bioactive epoxide moiety in pramanicin. Our work deciphers the biosynthetic pathway of a pharmaceutically relevant natural product, expands the enzymatic toolbox for synthetic biology by characterizing a novel family of membrane-associated biosynthetic enzymes.

## Linked entities

- **Genes:** praA (alkane oxidation protein activator PraA) [NCBI Gene 45487988], praB (alkane oxidation protein activator PraB) [NCBI Gene 45487987], PRAC1 (PRAC1 small nuclear protein) [NCBI Gene 84366]
- **Proteins:** praA (alkane oxidation protein activator PraA), praB (alkane oxidation protein activator PraB), PRAC1 (PRAC1 small nuclear protein)
- **Chemicals:** pramanicin (PubChem CID 10595278), pramanicin-A (PubChem CID 170989303), epoxide (PubChem CID 1742210)
- **Species:** Macrophomina phaseolina (taxon 35725), Aspergillus nidulans (taxon 162425)

## Full-text entities

- **Chemicals:** epoxide (MESH:D004852), pramanicin-A. (-), Pramanicin (MESH:C432807)
- **Species:** Aspergillus nidulans (species) [taxon 162425], Macrophomina phaseolina (charcoal rot, species) [taxon 35725]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12895699/full.md

---
Source: https://tomesphere.com/paper/PMC12895699